FDA Unlikely To Curb Off-Label Marketing: Sources
As pharmaceutical companies welcomed the U.S. Food and Drug Administration's proposed guidance detailing how journal articles on off-label drug uses can be distributed to doctors, consumer advocates have rebuked the agency...To view the full article, register now.
Already a subscriber? Click here to view full article